Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study.

Yosuke TakakusagiHidemasa KawamuraMasahiko OkamotoTakuya KaminumaNobuteru KuboTatsuji MizukamiHiro SatoMasahiro OnishiNobuaki OhtakeTetsuo SekiharaTakashi Nakano

Published in: PloS one (2019)

The present study demonstrated that HIMRT using TomoTherapy for prostate cancer has a favorable outcome with tolerable toxicity.

Keyphrases

prostate cancer
radical prostatectomy
radiation therapy
early stage
oxidative stress
radiation induced
locally advanced
small cell lung cancer
squamous cell carcinoma